Pulmonary hypertension among patients undergoing hemodialysis

Fatemeh Hayati ¹, Seyed Seifollah Beladi Mousavi ^1,2 * , Seyed Majid Mousavi Movahed ², Maryam Mofrad Bushehri ¹

Cited by CrossRef: 7

1- Havoshki Z, Khajeh Karimoddini Z, Miri M. Relationship Between Parathyroid Hormone and Pulmonary Artery Hypertension Among Patients Undergoing Hemodialysis. Nephro-Urol Mon. 2020;12(3) [Crossref]

2- Engole Y, Lepira F, Nlandu Y, Lubenga Y, Longo A, Nkodila A, Makulo J, Mokoli V, Bukabau J, Mboliasa M, Kadima E, Ilunga C, Mvunzi T, Nseka N, Sumaili E. Prevalence and factors associated with pulmonary arterial hypertension on maintenance hemodialysis patients in Kinshasa, Democratic Republic of Congo: a cross-sectional study. BMC Nephrol. 2020;21(1) [Crossref]

3- Alhwiesh A, Abdul-Rahman I, Alshehri A, Alhwiesh A, Elnokeety M, Essam S, Sakr M, Al-Oudah N, Abdulrahman A, Mohammed A, Mansour H, El-Salamoni T, Al-Oudah N, Alayoobi L, Aljenaidi H, Al-Harbi A, Mousa D, Abdulnasir A, Skhiri S. The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution. BMC Nephrol. 2022;23(1) [Crossref]

4- Schoenberg N, Argula R, Klings E, Wilson K, Farber H. Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysis. Lung. 2020;198(3):535 [Crossref]

5- Alıcı G, Waberi M, Mohamud M, Bashir A, Genç Ö. Pulmonary hypertension among maintenance hemodialysis patients in Somalia: a hospital-based observational study. Egypt Heart J. 2022;74(1) [Crossref]

6- Movahhed S. Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications. Naunyn-Schmiedeberg's Arch Pharmacol. 2021;394(8):1599 [Crossref]

7- Eskandarian R, Sakhdari M, Yarmohamadi M, Mirmohammadkhani M. Pulmonary Artery Pressure Status in Hemodialysis Patients and Its Association with Nutritional and Biochemical Markers. Middle East J Rehabil Health Stud. 2023;11(3) [Crossref]